Display Settings:

Format

Send to:

Choose Destination
    J Exp Med. 2005 May 2;201(9):1355-9.

    Blocking IL-1 in systemic inflammation.

    Source

    Division of Infectious Diseases, Department of Medicine, University of Colorado Health Sciences Center, Denver, CO 80262, USA. cdinare333@aol.com

    Abstract

    A growing number of systemic inflammatory diseases characterized in part by recurrent fevers, leukocytosis, anemia, and elevated acute phase proteins are linked to interleukin (IL)-1 activity since rapid and sustained resolution is observed upon specific blockade of IL-1 receptors. Rapid resolution of systemic and local inflammation is now also reported in systemic onset juvenile idiopathic arthritis (SoJIA). Loss of control of the secretion of IL-1beta might be a common mechanism explaining the aberrant activity of IL-1 in these diseases.

    PMID:
    15867089
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2213199
    Free PMC Article

    Images from this publication.See all images (2) Free text

    Figure 1.
    Figure 2.

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk